Danaher agrees to divest products where it competes directly with GE biopharma unit
Danaher agreed to divest 10 products in markets where the company competed head-to-head with General Electric’s biopharma business and where the market would have been left with just two significant players...To view the full article, register now.
Already a subscriber? Click here to view full article